Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析

◆英語タイトル:Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1300
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Edwards Lifesciences Corp (EW) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that develops, manufactures and markets devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, transcatheter heart valves, hemodynamic monitoring devices, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.

Edwards Lifesciences Corp Key Recent Developments

Mar 28,2020: Edwards pauses enrollments in pivotal mitral, tricuspid trials in response to hospitals’ focus on COVID-19
Feb 21,2020: Edwards Lifesciences’ Every Heartbeat Matters Philanthropic Initiative expanding to reach more patients
Jan 30,2020: Edwards Lifesciences reports fourth quarter results
Dec 05,2019: Edwards Lifesciences outlines growth strategy at annual investor conference 2019
Oct 23,2019: Edwards Lifesciences reports third quarter results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Edwards Lifesciences Corp – Key Facts
Edwards Lifesciences Corp – Key Employees
Edwards Lifesciences Corp – Key Employee Biographies
Edwards Lifesciences Corp – Major Products and Services
Edwards Lifesciences Corp – History
Edwards Lifesciences Corp – Company Statement
Edwards Lifesciences Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Edwards Lifesciences Corp – Business Description
Product Category: Critical Care
Overview
Performance
Product Category: Surgical Structural Heart
Overview
Performance
Product Category: Transcatheter Aortic Valve Replacement
Overview
Performance
Product Category: Transcatheter Mitral and Tricuspid Therapies
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Edwards Lifesciences Corp – Corporate Strategy
Edwards Lifesciences Corp – SWOT Analysis
SWOT Analysis – Overview
Edwards Lifesciences Corp – Strengths
Edwards Lifesciences Corp – Weaknesses
Edwards Lifesciences Corp – Opportunities
Edwards Lifesciences Corp – Threats
Edwards Lifesciences Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Edwards Lifesciences Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 21, 2020: Edwards Lifesciences’ Every Heartbeat Matters Philanthropic Initiative expanding to reach more patients
Jan 30, 2020: Edwards Lifesciences reports fourth quarter results
Dec 05, 2019: Edwards Lifesciences outlines growth strategy at annual investor conference 2019
Oct 23, 2019: Edwards Lifesciences reports third quarter results
Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica
Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019
Jun 21, 2019: Edwards comments on updated TAVR National Coverage Determination
Apr 23, 2019: Edwards Lifesciences announces first quarter results
Feb 13, 2019: Edwards Lifesciences to buy CASMED for $100m
Jan 31, 2019: Edwards Lifesciences reports financial results for the quarter ended December 31, 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Edwards Lifesciences Corp, Key Facts
Edwards Lifesciences Corp, Key Employees
Edwards Lifesciences Corp, Key Employee Biographies
Edwards Lifesciences Corp, Major Products and Services
Edwards Lifesciences Corp, History
Edwards Lifesciences Corp, Other Locations
Edwards Lifesciences Corp, Subsidiaries
Edwards Lifesciences Corp, Key Competitors
Edwards Lifesciences Corp, Ratios based on current share price
Edwards Lifesciences Corp, Annual Ratios
Edwards Lifesciences Corp, Annual Ratios (Cont...1)
Edwards Lifesciences Corp, Annual Ratios (Cont...2)
Edwards Lifesciences Corp, Interim Ratios
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Edwards Lifesciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Edwards Lifesciences Corp, Performance Chart (2015 - 2019)
Edwards Lifesciences Corp, Ratio Charts
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Edwards Lifesciences Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hengeler Mueller Partnerschaft von Rechtsanwalten mbB:企業の戦略的SWOT分析
    Hengeler Mueller Partnerschaft von Rechtsanwalten mbB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key com …
  • Nufarm Ltd (NUF):企業の財務・戦略的SWOT分析
    Nufarm Ltd (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dimension Data Holdings Plc:企業の戦略的SWOT分析
    Dimension Data Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • World Fuel Services Corp (INT):企業の財務・戦略的SWOT分析
    World Fuel Services Corp (INT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Becton Dickinson and Co (BDX):医療機器:M&Aディール及び事業提携情報
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply managemen …
  • Alberta Investment Management Corporation:企業の戦略・SWOT・財務情報
    Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report Summary Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • HC Slingsby Plc:企業の戦略・SWOT・財務情報
    HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report Summary HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kumiai Chemical Industry Co Ltd (4996):企業の財務・戦略的SWOT分析
    Summary Kumiai Chemical Industry Co Ltd (Kumiai Chemical) operates as a chemical company that develops, manufactures and markets agricultural chemicals, fine chemicals, and curing agents. The company's agricultural chemicals include bactericides, herbicides, fungicides, acaricides, microbial pestici …
  • Zagro Asia Ltd:企業の戦略的SWOT分析
    Zagro Asia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Euroclear Plc:企業の戦略・SWOT・財務分析
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Miracor Medical Systems GmbH:製品パイプライン分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • AutoZone Inc (AZO):企業の財務・戦略的SWOT分析
    AutoZone Inc (AZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pret A Manger Holdings Ltd.:企業の戦略・SWOT・財務情報
    Pret A Manger Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pret A Manger Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Selexys Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Selexys Pharmaceuticals Corp (Selexys Pharmaceuticals) is a biopharmaceutical company that develops drugs for the treatment of inflammatory and thrombotic diseases. The company’s products comprise Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating …
  • JBS S.A.:戦略・SWOT・企業財務分析
    JBS S.A. - Strategy, SWOT and Corporate Finance Report Summary JBS S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Trek 2000 International Ltd. (5AB):企業の財務・戦略的SWOT分析
    Trek 2000 International Ltd. (5AB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PFM Packaging Machinery S.p.a.:企業の戦略・SWOT・財務情報
    PFM Packaging Machinery S.p.a. - Strategy, SWOT and Corporate Finance Report Summary PFM Packaging Machinery S.p.a. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CGU Insurance Limited:企業の戦略・SWOT・財務情報
    CGU Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary CGU Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Schnell Biopharmaceuticals Inc (003060)-製薬・医療分野:企業M&A・提携分析
    Summary Schnell Biopharmaceuticals Inc (Schnell), formerly Korea Schnell Pharma Co., Ltd. is a healthcare company that offers agents and antibiotics. The company provides pharmaceutical products including amino acid infusion agents and antibiotics. Its products portfolio includes antibiotics, infusi …
  • Riot Blockchain Inc (RIOT):医療機器:M&Aディール及び事業提携情報
    Summary Riot Blockchain Inc (Riot Blockchain) builds, operates and supports blockchain technologies. Its primary operations include mining of cryptocurrencies and development of exchange and mining pool platforms. The company focuses on both Bitcoin and Ethereum blockchain ecosystems. Riot Blockchai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆